Skip to main navigation

About People Science Pipeline Patients Investors Careers

Overview
Vision & Values
Impact
Founder's Letter
Contact

Overview
Leadership Team
Board of Directors
Scientific Advisory Board
R&D Advisory Board

RAS/MAPK Pathway
MAPKlamp & More
Presentations & Publications

Pipeline
Programs
Clinical Trials

Patients & Caregivers
Clinical Trials

Corporate Overview
News & Events
Stock Information
Corporate Governance
Financial Information
Investor Resources

Dynamic Culture
Values & Attributes
Competitive Benefits
Open Positions

Stay in Touch

858.465.6511
info@erasca.com

News & Events

News Releases
Erasca in the News
Events
Presentations

News Releases

Year

05.12.2022

Erasca Reports First Quarter 2022 Financial Results and Business Updates

05.03.2022

Erasca to Present at the Bank of America Securities 2022 Healthcare Conference

04.27.2022

Erasca Appoints Jean Liu to its Board of Directors

04.12.2022

Erasca Presents Compelling Preclinical Data Supporting Clinical Development of Potentially Best-In-Class Programs ERAS-007, ERAS-601, and ERAS-3490 at 2022 AACR Annual Meeting

04.06.2022

Erasca To Host Investor Event with Leading KOL Dr. Scott Kopetz on Therapeutic Opportunities in Cancers Driven by the RAS/MAPK Pathway

03.24.2022

Erasca Reports Fourth Quarter 2021 Financial Results and Business Updates

03.10.2022

Erasca Announces Clinical Trial Collaboration and Supply Agreement with Eli Lilly and Company to Evaluate ERAS-007 and Cetuximab Combination

03.08.2022

Erasca Announces Six Poster Presentations at the 2022 AACR Annual Meeting

02.03.2022

Erasca to Present at the Guggenheim Healthcare Talks 2022 Oncology Day

01.18.2022

Erasca Strengthens Leadership Team with Two Key Executive Appointments

Pagination

First page
Previous page
Page 1
Current page 2
Page 3
Next page
Last page

Displaying 11 - 20 of 21

Site - Investor Tools

Contact Us

info@erasca.com

Location

ERASCA, INC.

3115 Merryfield Row

Suite 300

San Diego, CA 92121

Terms of Use
Privacy Policy

© 2021 Erasca™, Inc. All rights reserved.